ArticleJournal of cellular and molecular medicine2017

Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.

Ao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.